{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:42:51Z","timestamp":1784932971016,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>An efficient and safe vaccine is expected to allow people to return to normal life as soon as possible. However, vaccines for new diseases are likely to be in short supply during the initial deployment due to narrow production capacity and logistics. There is an urgent need to optimize the allocation of limited vaccines to improve the population effectiveness of vaccination. Existing studies mostly address a single epidemiological landscape. The robustness of the effectiveness of other proposed strategies is difficult to guarantee under other landscapes. In this study, a novel vaccination allocation model based on spatio-temporal heterogeneity of epidemiological landscapes is proposed. This model was combined with optimization algorithms to determine the near-optimal spatio-temporal allocation for vaccines with different effectiveness and coverage. We fully simulated the epidemiological landscapes during vaccination, and then minimized objective functions independently under various epidemiological landscapes and degrees of viral transmission. We find that if all subregions are in the middle or late stages of the pandemic, the difference between the effectiveness of the near-optimal and pro-rata strategies is very small in most cases. In contrast, under other epidemiological landscapes, when minimizing deaths, the optimizer tends to allocate the remaining doses to sub-regions with relatively higher risk and expected coverage after covering the elderly. While to minimize symptomatic infections, allocating vaccines first to the higher-risk sub-regions is near-optimal. This means that the pro-rata allocation is a good option when the subregions are all in the middle to late stages of the pandemic. Moreover, we suggest that if all subregions are in the period of rapid virus transmission, vaccines should be administered to older adults in all subregions simultaneously, while when the epidemiological dynamics of the subregions are significantly different, priority can be given to older adults in subregions that are still in the early stages of the pandemic. After covering the elderly in the region, high-risk sub-regions can be prioritized.<\/jats:p>","DOI":"10.3389\/fpubh.2022.921855","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T13:14:08Z","timestamp":1655990048000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes"],"prefix":"10.3389","volume":"10","author":[{"given":"Wen","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","unstructured":"Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)2019"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1008274","DOI":"10.1371\/journal.pcbi.1008274","article-title":"Quantifying the impact of COVID-19 control measures using a Bayesian model of physical distancing","volume":"16","author":"Anderson","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/ijgi10070480","article-title":"Analysis and evaluation of non-pharmaceutical interventions on prevention and control of COVID-19: a case study of Wuhan City","volume":"10","author":"Cao","year":"2021","journal-title":"ISPRS Int J Geo-Inf."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1473-3099(20)30361-3","article-title":"Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study","volume":"20","author":"Peak","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/d41586-020-01063-8","article-title":"If a coronavirus vaccine arrives, can the world make enough","volume":"580","author":"Khamsi","year":"2020","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0140-6736(20)31354-4","article-title":"COVID-19 vaccines for all?","volume":"395","author":"Usher","year":"2020","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2000298","DOI":"10.1002\/adts.202000298","article-title":"The signature features of COVID-19 pandemic in a hybrid mathematical model\u2014implications for optimal work\u2013school lockdown policy","volume":"4","author":"Lazebnik","year":"2021","journal-title":"Adv Theory Simul."},{"key":"B8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jtbi.2005.04.017","article-title":"Modeling polio as a disease of development","volume":"237","author":"Bunimovich-Mendrazitsky","year":"2005","journal-title":"J Theor Biol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1515\/ijnsns-2021-0063","article-title":"Pandemic management by a spatio\u2013temporal mathematical model","author":"Lazebnik","year":"2021","journal-title":"Int J Nonlinear Sci Numer Simul."},{"key":"B10","doi-asserted-by":"publisher","first-page":"106617","DOI":"10.1016\/j.aml.2020.106617","article-title":"Simulating the spread of COVID-19 via a spatially- resolved susceptible\u2013exposed\u2013infected\u2013recovered\u2013deceased (SEIRD) model with heterogeneous diffusion","volume":"111","author":"Viguerie","year":"2021","journal-title":"Appl Math Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.abe6959","article-title":"Model-informed COVID-19 vaccine prioritizationstrategies by age and serostatus","volume":"371","author":"Bubar","year":"2021","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijid.2020.12.075","article-title":"Comparing COVID-19 vaccine allocation strategies in India: a mathematical modelling study","volume":"103","author":"Foy","year":"2021","journal-title":"Int J Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"106176","DOI":"10.1016\/j.cnsns.2021.106176","article-title":"Comparison of pandemic intervention policies in several building types using heterogeneous population model","volume":"107","author":"Lazebnik","year":"2022","journal-title":"Commun Nonlinear Sci Numer Simul."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S1473-3099(21)00057-8","article-title":"Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study","volume":"21","author":"Jentsch","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23761-1","article-title":"Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination","volume":"12","author":"Matrajt","year":"2021","journal-title":"Nat Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"abf1374","DOI":"10.1126\/sciadv.abf1374","article-title":"Vaccine optimization for COVID-19: who to vaccinate first?","volume":"7","author":"Matrajt","year":"2021","journal-title":"Sci Adv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10729-012-9199-6","article-title":"Geographic prioritization of distributing pandemic influenza vaccines","volume":"15","author":"Araz","year":"2012","journal-title":"Health Care Manag Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"20141341","DOI":"10.1098\/rspb.2014.1341","article-title":"Reactive vaccination in the presence of disease hotspots","volume":"282","author":"Azman A","year":"2015","journal-title":"Proc R Soc B Biol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1098\/rspb.2007.0893","article-title":"Spatial considerations for the allocation of pre-pandemic influenza vaccination in the United States","volume":"274","author":"Wu","year":"2007","journal-title":"Proc R Soc B Biol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.3390\/ijerph18115636","article-title":"The use of GIS technology to optimize COVID-19 vaccine distribution: a case study of the city of Warsaw, Poland","volume":"18","author":"Krzysztofowicz","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2021GH000427","DOI":"10.1029\/2021GH000427","article-title":"Optimizing spatial allocation of COVID-19 vaccine by agent-based spatiotemporal simulations","volume":"5","author":"Zhou","year":"2021","journal-title":"GeoHealth"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1007111","DOI":"10.1371\/journal.pcbi.1007111","article-title":"Optimizing spatial allocation of seasonal influenza vaccine under temporal constraints","volume":"15","author":"Venkatramanan","year":"2019","journal-title":"PLoS Comput Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1009974","DOI":"10.1371\/journal.pcbi.1009974","article-title":"Adaptive and optimized COVID-19 vaccination strategies across geographical regions and age groups","volume":"18","author":"Molla","year":"2022","journal-title":"PLoS Comput Biol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.06.21256732","article-title":"Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study","author":"Lemaitre","year":"2022","journal-title":"medRxiv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1473-3099(21)00676-9","article-title":"Protective immunity after recovery from SARS-CoV-2 infection","volume":"22","author":"Kojima","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.immuni.2020.07.005","article-title":"Lessons for COVID-19 immunity from other coronavirus infections","volume":"53","author":"Sariol","year":"2020","journal-title":"Immunity."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1005697","DOI":"10.1371\/journal.pcbi.1005697","article-title":"Projecting social contact matrices in 152 countries using contactsurveys and demographic data","volume":"13","author":"Prem","year":"2017","journal-title":"PLoS Comput Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1006638","DOI":"10.1371\/journal.pcbi.1006638","article-title":"Projecting social contact matrices to different demographic structures","volume":"14","author":"Arregui","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"B34","unstructured":"Projections"},{"key":"B35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7326\/M20-6169","article-title":"Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials","volume":"174","author":"Mehrotra","year":"2021","journal-title":"Ann Int Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","article-title":"Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission","volume":"180","author":"Van den Driessche","year":"2002","journal-title":"Math Biosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","volume":"26","author":"Davies","year":"2020","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1126\/science.abd7672","article-title":"Epidemiology and transmission dynamics of COVID-19 in two Indian states","volume":"370","author":"Laxminarayan","year":"2020","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.921855\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T13:14:12Z","timestamp":1655990052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.921855\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":40,"alternative-id":["10.3389\/fpubh.2022.921855"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.921855","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"921855"}}